Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05106257 · ClinicalTrials.gov registry record · NA
Optimizing Self-management COPD Treatment Through the American Lung Association Helpline
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05106257: Completed NA study, sponsored by Rush University Medical Center.
NCT05106257 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05106257, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Although self-management treatment improves quality of life among individuals with COPD, there is limited understanding of which elements of treatment are most effective. The proposed research will test the feasibility of using an engineering-inspired study design to identify effective COPD self-management treatment components. The long-term goal of this line of research is to optimize the effectiveness of COPD self-management treatment, and improve quality of life for individuals with COPD.
Primary Outcome
Measured by the Chronic Respiratory Disease Questionnaire (CRQ) dyspnea subscale score. Possible scale range is 1-7; higher scores indicate better health-related quality of life.
Interventions
- BEHAVIORAL Self-management education (short)
- BEHAVIORAL Ground-based walking training
- BEHAVIORAL Inhaler training
- BEHAVIORAL Caregiver support
- BEHAVIORAL Self-management education (long)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-11-05 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT05106257 record still lists
NCT05106257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Self-management education (short) is the first listed.
NCT05106257 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05106257 about?
NCT05106257 is a clinical study titled "Optimizing Self-management COPD Treatment Through the American Lung Association Helpline". Although self-management treatment improves quality of life among individuals with COPD, there is limited understanding of which elements of treatment are most effective. The proposed research will test the feasibility of using an engineering-inspired study design to identify effective COPD self-man...
What is the current status of trial NCT05106257?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-11-05. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05106257?
The interventions under investigation include: Self-management education (short) (BEHAVIORAL), Ground-based walking training (BEHAVIORAL), Inhaler training (BEHAVIORAL), Caregiver support (BEHAVIORAL), Self-management education (long) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05106257?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05106257's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI